ICON Public Limited Company
$114.42
▼
-0.66%
2026-04-22 10:12:13
www.iconplc.com
NMS: ICLR
Explore ICON Public Limited Company stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$8.76 B
Current Price
$114.42
52W High / Low
$211 / $66.57
Stock P/E
15.51
Book Value
$122.25
Dividend Yield
—
ROCE
8.66%
ROE
6.27%
Face Value
—
EPS
$7.4
Exp Qtr EPS
—
Sector
Healthcare
Industry
Diagnostics & Research
Employees
39,800
Beta
1.28
Debt / Equity
38.26
Current Ratio
1.06
Quick Ratio
1.26
Forward P/E
8.68
Price / Sales
1.03
Enterprise Value
$11.26 B
EV / EBITDA
7.4
EV / Revenue
1.39
Rating
Buy
Target Price
$131.92
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Some data points may be missing or delayed because the source is not an official exchange feed.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Inotiv, Inc. | $0.29 | — | $9.46 M | — | -17.26% | -49.76% | $3.32 / $0.22 | $3.17 |
| 2. | Natera, Inc. | $206.53 | — | $29.47 B | — | -15.84% | -14.32% | $256.36 / $131.81 | $12.26 |
| 3. | NeoGenomics, Inc. | $8.23 | — | $1.06 B | — | -6.93% | -12.43% | $13.74 / $4.72 | $6.49 |
| 4. | GRAIL, Inc. | $51.2 | — | $2.1 B | — | -18.79% | -16.07% | $118.84 / $25.56 | $63.92 |
| 5. | Mainz Biomed N.V. | $0.47 | — | $5.89 M | — | -252.7% | -4.88% | $4.43 / $0.4 | $0.62 |
| 6. | BillionToOne, Inc. | $86.97 | 489.81 | $3.65 B | — | 2.74% | 2.3% | $138.7 / $61.96 | $10.48 |
| 7. | Mettler-Toledo International Inc. | $1,328.56 | 31.6 | $26.93 B | — | 44.48% | -1154.87% | $1,525.17 / $962.54 | $-1.16 |
Quarterly Results
Figures shown in M / B
| Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|
| Sales | 2.04 B | 2.02 B | 2 B | 2.04 B | 2.03 B |
| Operating Profit | 258.9 M | 258.88 M | 264.31 M | 351.26 M | 293.29 M |
| Net Profit | 2.35 M | 182.97 M | 154.15 M | 260 M | 197.13 M |
| EPS in Rs | 0.03 | 2.4 | 2.02 | 3.4 | 2.58 |
Profit & Loss
Figures shown in M / B
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Sales | 8.28 B | 8.12 B | 7.74 B | 5.48 B |
| Operating Profit | 1.22 B | 1.05 B | 866.08 M | 607.9 M |
| Net Profit | 791.47 M | 612.34 M | 505.3 M | 153.19 M |
| EPS in Rs | 10.37 | 8.02 | 6.62 | 2.01 |
Balance Sheet
Figures shown in M / B
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Total Assets | 16.88 B | 16.99 B | 17.19 B | 17.39 B |
| Total Liabilities | 7.35 B | 7.75 B | 8.69 B | 9.32 B |
| Equity | 9.52 B | 9.24 B | 8.5 B | 8.07 B |
| Current Assets | 3.53 B | 3.41 B | 3.23 B | 2.94 B |
| Current Liabilities | 2.8 B | 2.83 B | 2.69 B | 2.48 B |
Cash Flow
Last available yearly cash flow history
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Operating CF | 1.29 B | 1.16 B | 563.32 M | 829.14 M |
| Investing CF | -266.79 M | -226.65 M | -145.87 M | -6.02 B |
| Financing CF | -837.18 M | -844.04 M | -864.17 M | 5.11 B |
| Free CF | 1.12 B | 1.02 B | 421.15 M | 735.39 M |
| Capex | -168.06 M | -140.69 M | -142.16 M | -93.75 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 1.99% | 4.89% | 41.24% | — |
| Earnings Growth % | 29.26% | 21.18% | 229.87% | — |
| Profit Margin % | 9.56% | 7.54% | 6.53% | 2.79% |
| Operating Margin % | 14.73% | 12.88% | 11.19% | 11.09% |
| Gross Margin % | 29.42% | 29.56% | 28.6% | 27.52% |
| EBITDA Margin % | 18.88% | 18.74% | 17.39% | 11.05% |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.